Home/Tolerance Bio/Phil Ball, PhD

PB

Phil Ball, PhD

Chief Business Officer

Therapeutic Areas

Oncology Autoimmune Diseases Transplant Medicine Immunodeficiency Allergy

Tolerance Bio Pipeline

Drug	Indication	Phase
iPSC-derived Thymic Organoids	Immune Reconstitution / Oncology (e.g., Melanoma)	Pre-clinical

Leadership Team at Tolerance Bio

Francisco Leon, MD, PhD

Founder and CEO

Holger Russ, PhD

Scientific Co-founder

Chief Financial Officer

Yeh-Chuin Poh, PhD

SVP, Head of Tech Ops

View full Tolerance Bio profile